Thomas R. Staab II

CIK: 0001230708

Transaction Breakdown

Open Market Buys (P)1 (12.5%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (12.5%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TENX

TENAX THERAPEUTICS, INC.

Officer

LNSR

LENSAR, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

TENX
TENAX THERAPEUTICS, INC.
Sep 11, 2026
Purchase(P)
Direct
5.7K shares at avg. $1.94$11K
TENX
TENAX THERAPEUTICS, INC.
May 11, 2026
Award(A)
Direct
10K shares-
LNSR
LENSAR, Inc.
May 6, 2026
Tax Payment(F)
Direct
1.4K shares at avg. $5.38$7K
LNSR
LENSAR, Inc.
Mar 19, 2026
Exercise(M)
Direct
5.5K shares at avg. $2.65$15K
LNSR
LENSAR, Inc.
Feb 18, 2026
Tax Payment(F)
Direct
1.1K shares at avg. $11.32$12K
LNSR
LENSAR, Inc.
Jan 11, 2026
Tax Payment(F)
Direct
1.8K shares at avg. $11.57$21K
LNSR
LENSAR, Inc.
Feb 18, 2025
Award(A)
Direct
12.8K shares-
LNSR
LENSAR, Inc.
Jan 11, 2025
Tax Payment(F)
Direct
1.8K shares at avg. $8.25$15K

		Type	Shares	Price		Ownership
Sep 11, 2026	TENX TENAX THERAPEUTICS, INC.	Purchase(P)	5,675	$1.94	$10,981	Direct
May 11, 2026	TENX TENAX THERAPEUTICS, INC.	Award(A)	10,000	-	$0	Direct
May 6, 2026	LNSR LENSAR, Inc.	Tax Payment(F)	1,350	$5.38	$7,270	Direct
Mar 19, 2026	LNSR LENSAR, Inc.	Exercise(M)	5,500	$2.65	$14,575	Direct
Feb 18, 2026	LNSR LENSAR, Inc.	Tax Payment(F)	1,076	$11.32	$12,180	Direct
Jan 11, 2026	LNSR LENSAR, Inc.	Tax Payment(F)	1,826	$11.57	$21,127	Direct
Feb 18, 2025	LNSR LENSAR, Inc.	Award(A)	12,766	-	-	Direct
Jan 11, 2025	LNSR LENSAR, Inc.	Tax Payment(F)	1,839	$8.25	$15,172	Direct

1-8 of 8 transactions

About STAAB THOMAS R II

STAAB THOMAS R II (SEC CIK 0001230708) files insider reports with the SEC as Chief Financial Officer of TENAX THERAPEUTICS, INC. (TENX) and Chief Financial Officer of LENSAR, Inc. (LNSR).

Signal8 holds 9 ownership filings by STAAB THOMAS R II (1 Form 3, 8 Form 4), filed between Feb 6, 2025 and Sep 15, 2026. Those filings report 8 transactions, from Jan 11, 2025 to Sep 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on STAAB THOMAS R II's filings is in CHAPEL HILL, NC.

Recent filings by STAAB THOMAS R II

Sep 11, 2026: Open-market purchase of TENX shares (Form 4, code P).
May 11, 2026: Grant or award of TENX shares (Form 4, code A).
May 6, 2026: Tax withholding of LNSR shares (Form 4, code F).
Mar 19, 2026: Option exercise of LNSR shares (Form 4, code M).
Feb 18, 2026: Tax withholding of LNSR shares (Form 4, code F).

Other insiders filing for TENAX THERAPEUTICS, INC. (TENX)

ADAR1 Capital Management, LLC, 10% Owner
Doogan Declan, Director
Giordano Christopher Thomas, CEO
MCGAULEY THOMAS, Interim CFO
Davidson Michael H., Director
Rich Stuart, Chief Medical Officer

How to read Form 4 transaction codes